Minimally Invasive Delivery of Hydrogel-Encapsulated Amiodarone to the Epicardium Reduces Atrial Fibrillation

Circulation. Arrhythmia and Electrophysiology
Jose R GarciaRebecca D Levit

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Although treatment options for AF exist, many patients cannot be maintained in normal sinus rhythm. Amiodarone is an effective medication for AF but has limited clinical utility because of off-target tissue toxicity. Here, we use a pig model of AF to test the efficacy of an amiodarone-containing polyethylene glycol-based hydrogel. The gel is placed directly on the atrial epicardium through the pericardial space in a minimally invasive procedure using a specially designed catheter. Implantation of amiodarone-containing gel significantly reduced the duration of sustained AF at 21 and 28 days; inducibility of AF was reduced 14 and 21 days post-delivery. Off-target organ drug levels in the liver, lungs, thyroid, and fat were significantly reduced in animals treated with epicardial amiodarone gel compared with systemic controls in small-animal distribution studies. The pericardium is an underutilized therapeutic site and may be a new treatment strategy for AF and other cardiovascular diseases.

References

Mar 27, 1998·European Journal of Clinical Pharmacology·R CandinasF Follath
Sep 14, 2001·European Journal of Drug Metabolism and Pharmacokinetics·T A Najjar
Apr 19, 2002·The Journal of Pharmacology and Experimental Therapeutics·J J Rob HermansJos F M Smits
Dec 6, 2002·The New England Journal of Medicine·D G WyseUNKNOWN Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators
Jun 4, 2004·Journal of Cardiovascular Pharmacology·Thomas J van BrakelJos G Maessen
Sep 16, 2004·Cardiovascular Drugs and Therapy·András VereckeiDouglas P Zipes
Jun 21, 2008·The New England Journal of Medicine·Denis RoyUNKNOWN Atrial Fibrillation and Congestive Heart Failure Investigators
Oct 31, 2009·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Kunihiro NishidaStanley Nattel
Mar 6, 2010·International Journal of Cardiology·Robert W BoldermanJos G Maessen
May 5, 2011·Circulation. Cardiovascular Quality and Outcomes·Michael H KimKathy L Schulman
Oct 16, 2012·Journal of the American College of Cardiology·Roland Richard TilzFeifan Ouyang
Feb 22, 2013·Science Translational Medicine·Sonya B Seif-NaraghiKaren L Christman
Oct 12, 2013·Journal of the American Heart Association·Rebecca D LevitW Robert Taylor
Dec 25, 2013·The Heart Surgery Forum·Juan MarcanoWilliam E Cohn
Mar 13, 2014·Pharmacoepidemiology and Drug Safety·Amarsinh M DesaiChristina M L Kelton
Apr 20, 2014·Journal of Cardiovascular Pharmacology and Therapeutics·Ziv BeckermanGil Bolotin
Jul 22, 2014·The Journal of Thoracic and Cardiovascular Surgery·Xiao Dong FengWilliam Wang
Dec 19, 2014·Circulation·Dariush MozaffarianUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Mar 20, 2015·Drug Delivery and Translational Research·Edward A PhelpsAndrés J García
Feb 14, 2016·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Dhanunjaya LakkireddyDavid Wilber
Aug 5, 2016·Nature Reviews. Cardiology·Stanley Nattel, Dobromir Dobrev
Jul 30, 2017·The Canadian Journal of Cardiology·Jason G AndradeJohn Cairns
Aug 1, 2018·JACC. Basic to Translational Science·Jose R GarciaRebecca D Levit

❮ Previous
Next ❯

Citations

Jan 16, 2021·Drug Delivery and Translational Research·David S MonahanAamir Hameed
Apr 23, 2021·Arteriosclerosis, Thrombosis, and Vascular Biology·Michael N SayeghRebecca D Levit
Apr 24, 2021·Trends in Cardiovascular Medicine·Hei Ming Kenneth HoRichard M Day

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.